Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.

Lipotoxicity of the heart has been implicated as a leading cause of morbidity in Type 2 Diabetes Mellitus (T2DM). While numerous reports have demonstrated increased myocardial fatty acid (FA) utilization in obese T2DM animal models, this diabetic phenotype has yet to be demonstrated in non-obese ani...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Sriram Devanathan, Samuel T Nemanich, Attila Kovacs, Nicole Fettig, Robert J Gropler, Kooresh I Shoghi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Online Access:http://europepmc.org/articles/PMC3804536?pdf=render
_version_ 1857126728991768576
author Sriram Devanathan
Samuel T Nemanich
Attila Kovacs
Nicole Fettig
Robert J Gropler
Kooresh I Shoghi
author_facet Sriram Devanathan
Samuel T Nemanich
Attila Kovacs
Nicole Fettig
Robert J Gropler
Kooresh I Shoghi
author_sort Sriram Devanathan
collection DOAJ
container_title PLoS ONE
description Lipotoxicity of the heart has been implicated as a leading cause of morbidity in Type 2 Diabetes Mellitus (T2DM). While numerous reports have demonstrated increased myocardial fatty acid (FA) utilization in obese T2DM animal models, this diabetic phenotype has yet to be demonstrated in non-obese animal models of T2DM. Therefore, the present study investigates functional, metabolic, and genomic differences in myocardial FA metabolism in non-obese type 2 diabetic rats. The study utilized Goto-Kakizaki (GK) rats at the age of 24 weeks. Each rat was imaged with small animal positron emission tomography (PET) to estimate myocardial blood flow (MBF) and myocardial FA metabolism. Echocardiograms (ECHOs) were performed to assess cardiac function. Levels of triglycerides (TG) and non-esterified fatty acids (NEFA) were measured in both plasma and cardiac tissues. Finally, expression profiles for 168 genes that have been implicated in diabetes and FA metabolism were measured using quantitative PCR (qPCR) arrays. GK rats exhibited increased NEFA and TG in both plasma and cardiac tissue. Quantitative PET imaging suggests that GK rats have increased FA metabolism. ECHO data indicates that GK rats have a significant increase in left ventricle mass index (LVMI) and decrease in peak early diastolic mitral annular velocity (E') compared to Wistar rats, suggesting structural remodeling and impaired diastolic function. Of the 84 genes in each the diabetes and FA metabolism arrays, 17 genes in the diabetes array and 41 genes in the FA metabolism array were significantly up-regulated in GK rats. Our data suggest that GK rats' exhibit increased genomic disposition to FA and TG metabolism independent of obesity.
format Article
id doaj-art-2f3cd550e1174bea97c8dfd522f8d4ed
institution Directory of Open Access Journals
issn 1932-6203
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
spelling doaj-art-2f3cd550e1174bea97c8dfd522f8d4ed2025-08-19T19:07:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7847710.1371/journal.pone.0078477Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.Sriram DevanathanSamuel T NemanichAttila KovacsNicole FettigRobert J GroplerKooresh I ShoghiLipotoxicity of the heart has been implicated as a leading cause of morbidity in Type 2 Diabetes Mellitus (T2DM). While numerous reports have demonstrated increased myocardial fatty acid (FA) utilization in obese T2DM animal models, this diabetic phenotype has yet to be demonstrated in non-obese animal models of T2DM. Therefore, the present study investigates functional, metabolic, and genomic differences in myocardial FA metabolism in non-obese type 2 diabetic rats. The study utilized Goto-Kakizaki (GK) rats at the age of 24 weeks. Each rat was imaged with small animal positron emission tomography (PET) to estimate myocardial blood flow (MBF) and myocardial FA metabolism. Echocardiograms (ECHOs) were performed to assess cardiac function. Levels of triglycerides (TG) and non-esterified fatty acids (NEFA) were measured in both plasma and cardiac tissues. Finally, expression profiles for 168 genes that have been implicated in diabetes and FA metabolism were measured using quantitative PCR (qPCR) arrays. GK rats exhibited increased NEFA and TG in both plasma and cardiac tissue. Quantitative PET imaging suggests that GK rats have increased FA metabolism. ECHO data indicates that GK rats have a significant increase in left ventricle mass index (LVMI) and decrease in peak early diastolic mitral annular velocity (E') compared to Wistar rats, suggesting structural remodeling and impaired diastolic function. Of the 84 genes in each the diabetes and FA metabolism arrays, 17 genes in the diabetes array and 41 genes in the FA metabolism array were significantly up-regulated in GK rats. Our data suggest that GK rats' exhibit increased genomic disposition to FA and TG metabolism independent of obesity.http://europepmc.org/articles/PMC3804536?pdf=render
spellingShingle Sriram Devanathan
Samuel T Nemanich
Attila Kovacs
Nicole Fettig
Robert J Gropler
Kooresh I Shoghi
Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.
title Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.
title_full Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.
title_fullStr Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.
title_full_unstemmed Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.
title_short Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.
title_sort genomic and metabolic disposition of non obese type 2 diabetic rats to increased myocardial fatty acid metabolism
url http://europepmc.org/articles/PMC3804536?pdf=render
work_keys_str_mv AT sriramdevanathan genomicandmetabolicdispositionofnonobesetype2diabeticratstoincreasedmyocardialfattyacidmetabolism
AT samueltnemanich genomicandmetabolicdispositionofnonobesetype2diabeticratstoincreasedmyocardialfattyacidmetabolism
AT attilakovacs genomicandmetabolicdispositionofnonobesetype2diabeticratstoincreasedmyocardialfattyacidmetabolism
AT nicolefettig genomicandmetabolicdispositionofnonobesetype2diabeticratstoincreasedmyocardialfattyacidmetabolism
AT robertjgropler genomicandmetabolicdispositionofnonobesetype2diabeticratstoincreasedmyocardialfattyacidmetabolism
AT kooreshishoghi genomicandmetabolicdispositionofnonobesetype2diabeticratstoincreasedmyocardialfattyacidmetabolism